Incidence of upper gastrointestinal cancers of the oesophagus and stomach show a strong unexplained male predominance. Hormonal and reproductive factors have been associated with upper gastrointestinal cancers in women but there is little available data on men. To investigate this, we included 219,425 men enrolled in the UK Biobank in 2006-2010. Baseline assessments provided information on hormonal and reproductive factors (specifically hair baldness, number of children fathered, relative age at first facial hair and relative age voice broke) and incident oesophageal or gastric cancers were identified through linkage to U.K. cancer registries. Unadjusted and adjusted hazard ratios (HR) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. During 8 years of follow-up, 309 oesophageal 210 gastric cancers occurred. There was some evidence that male pattern baldness, was associated with gastric cancer risk (adjusted HR 1.35, 95% CI 0.97, 1.88), particularly for frontal male pattern baldness (adjusted HR 1.52, 95% CI 1.02, 2.28). There was little evidence of association between other hormonal and reproductive factors and risk of oesophageal or gastric cancer, overall or by histological subtype. In the first study of a range of male hormonal and reproductive factors and gastric cancer, there was a suggestion that male pattern baldness, often used as a proxy of sex hormone levels, may be associated with gastric cancer. Future prospective studies that directly test circulating sex steroid hormone levels in relation to upper gastrointestinal cancer risk are warranted.
Incidence of upper gastrointestinal cancers of the oesophagus and stomach show a strong unexplained male predominance. Hormonal and reproductive factors have been associated with upper gastrointestinal cancers in women but there is little available data on men. To investigate this, we included 219,425 men enrolled in the UK Biobank in 2006-2010. Baseline assessments provided information on hormonal and reproductive factors (specifically hair baldness, number of children fathered, relative age at first facial hair and relative age voice broke) and incident oesophageal or gastric cancers were identified through linkage to U.K. cancer registries. Unadjusted and adjusted hazard ratios (HR) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. During 8 years of follow-up, 309 oesophageal 210 gastric cancers occurred. There was some evidence that male pattern baldness, was associated with gastric cancer risk (adjusted HR 1.35, 95% CI 0.97, 1.88), particularly for frontal male pattern baldness (adjusted HR 1.52, 95% CI 1.02, 2.28). There was little evidence of association between other hormonal and reproductive factors and risk of oesophageal or gastric cancer, overall or by histological subtype. In the first study of a range of male hormonal and reproductive factors and gastric cancer, there was a suggestion that male pattern baldness, often used as a proxy of sex hormone levels, may be associated with gastric cancer. Future prospective studies that directly test circulating sex steroid hormone levels in relation to upper gastrointestinal cancer risk are warranted.
Upper gastrointestinal cancers of the oesophagus and stomach account for 455,800 and 951,600 new cancers diagnosed worldwide, respectively. 1 Significant morbidity and mortality is associated with these cancers; in the United Kingdom, only 15% of oesophageal and 19% of gastric cancer patients survive more than five years after diagnosis, [2] [3] [4] underlining the need for better understanding of aetiological factors to aid prevention. The most striking epidemiological feature of these cancers is their strong male predominance, 5, 6 which is most obvious for adenocarcinomas 7, 8 and is suggestive of sex steroid hormone involvement (including oestrogens and androgens). Testosterone, an important anabolic hormone, increases tissue proliferation and has been shown to stimulate the growth of cancer cells in vitro. 9, 10 Increased levels of testosterone in men and women has been associated with a 30-80% increase in early death after cancer diagnosis. 11 With regard to upper gastrointestinal cancers specifically, mounting preclinical evidence suggests that androgens and androgen receptor-signalling may be important in their pathogenesis; testosterone supresses wound healing and castration in male rats has been shown to inhibit gastric carcinogenesis.
Rates of oesophageal cancer (and specifically oesophageal adenocarcinoma) among men with a previous prostate cancer diagnosis are lower than expected, indicating that the androgen-lowering effects of androgen deprivation therapy may be contributing to a reduced oesophageal cancer risk. 21, 22 Only one study has evaluated the influence of reproductive factors and risk of upper gastrointestinal cancer in men. 23 Lu et al. observed significant reductions in oesophageal adenocarcinoma and oesophageal squamous cell carcinoma risk in men who had fathered children and in men who were older at first fatherhood in a case-control study that utilised administrative record linkages in Sweden. 23 However, only oesophageal cancer was evaluated in this study and other important markers of male sex hormone exposure (such as male pattern baldness pattern) were not investigated.
Further aetiological research to understand why upper gastrointestinal cancer rates are so much higher in men than women has been highlighted as a priority in the gastrointestinal cancer field. 7 We therefore prospectively investigated novel associations between hormonal and reproductive factors and risk of oesophageal and gastric cancer in a large U.K. population-based cohort of middle-aged men.
Material and Methods

Data sources
The UK Biobank is a large prospective cohort study which recruited over 500,000 men and women aged 40-69 years from one of 22 assessment centres located across England, Scotland and Wales between 2006 and 2010. 24 Touchscreen questionnaires were used at baseline to obtain information on a wide range of risk factors for chronic disease (e.g., demographics, diet, lifestyle, prior medical history and reproductive factors). Anthropometric measurements including height, weight, waist and hip circumference were also obtained at baseline. The UK Biobank is routinely linked to U.K. cancer registry data from the Health and Social Care Information Centre (in England and Wales) and the Scottish Cancer Registry (in Scotland) and death records from the U.K. Office of National Statistics (ONS). The UK Biobank was approved by the North West Multi-Centre Research Ethics Committee, and all participants provided written informed consent.
Study population
We included men enrolled in the UK Biobank without a previous history of cancer (excluding non-melanoma skin cancer) at or before baseline. Incident cases of oesophageal (ICD 10 C15) and gastric cancer (ICD 10 C16) were identified through linkage to U.K. national cancer registries. Cases of oesophageal and gastric cancer were further classed by histology, as adenocarcinoma (ICD-O morphology codes 8140-8573) or squamous cell carcinoma (ICD-O 8050-8082). Gastric cancers were classed by location, where possible, as cancers of the gastric cardia (C16.0) and gastric non-cardia sites (C16.1-16.5). Participants were followed from baseline until cancer diagnosis, emigration, death or end of follow-up (October 2014).
Hormonal and reproductive factors
Hormonal exposures included male pattern baldness and male pattern baldness pattern, fathered children status, number of children fathered, relative age at first facial hair and relative age at first voice broke were obtained from participants at baseline (from touchscreen questions). Participants with missing data for an exposure of interest were excluded from the relevant analysis.
Covariates
Information on risk factors for upper gastrointestinal cancers was retrieved from electronic touchscreen records collected at baseline and included smoking history, alcohol consumption and dietary factors (e.g., average weekly intakes of fruit and vegetables, red and processed meat). Body mass index (BMI) and waist-to-hip ratio was measured at baseline. Socioeconomic deprivation was retrieved from Townsend score (based on postcode of usual residence 25 ).
Statistical analysis
Baseline cohort characteristics were compared between oesophageal or gastric cancer cases and non-cases using v 2 tests for categorical variables. Cox proportional hazards regression models (with age as the underlying timescale variable) were used to estimate the unadjusted and adjusted hazard ratios (HR) and corresponding 95% confidence intervals (CI) for associations between hormonal and reproductive factors and risks of oesophageal and gastric cancer. All analyses were adjusted for age (as the underlying timescale), Townsend ), waist-to-hip ratio according to whether it met the guideline of the International Diabetes Federation criteria (94 cm in men) 26 and average weekly intakes of fruit and vegetables (<2, 2-5, >5). Additional adjustments were made for average weekly intakes of red meat (Never/<1, 1-3, >3) and processed meat (Never/<1, 1, >1). Sub-group analyses were conducted by histology (oesophageal adenocarcinoma and squamous cell carcinoma) and gastric cancer location (gastric cardia and non-cardia).
Results
UK Biobank cohort
A total of 219,426 men were included in the final cohort, following exclusion of 9,748 participants with a previous history of cancer. Of these, 309 men were diagnosed with oesophageal cancer and 210 were diagnosed with gastric cancer during a mean follow-up of 5.5 years (maximum 8.5 years). Baseline characteristics of oesophageal and gastric cancer cases and non-cases are presented in Table 1 . Oesophageal and gastric cancer cases were more likely to be older, be current and former heavy smokers, be former alcohol drinkers, be obese and have a higher waist-to-hip ratio while oesophageal cancer cases were also more likely to report higher weekly intakes of red and processed meat.
Association between hormonal and reproductive factors and risk of oesophageal and gastric cancer
Results for associations between male hormonal and reproductive factors and risk of oesophageal and gastric cancer are listed in Table 2 . Overall, no significant associations were observed for any of the hormonal exposures and risk of oesophageal cancer. For gastric cancer, there was a suggestion that men who reported having male pattern baldness had an increased risk of gastric cancer compared to those who reported no male pattern baldness, albeit the result failed to reach statistical significance (adjusted HR 1.35, 95% CI 0.97, 1.88; p 5 0.08). Frontal only male pattern baldness was significantly associated with an increased risk of gastric cancer compared to no male pattern baldness (adjusted HR 1.52, 95% CI 1.02, 2.28). Other markers of sex hormone exposure were not associated with gastric cancer including fathered children, increasing number of children fathered, relative age at first facial hair or relative age voice broke. The findings were not materially altered following additional adjustments for red and processed meat intakes (data not shown).
Sub group analysis by histological subtype and tumour location
Results by histological subtype including oesophageal adenocarcinoma, oesophageal squamous cell carcinoma and gastric adenocarcinoma are presented in Table 3 . Overall, no significant associations were observed for any of the examined hormonal or reproductive factors and risk of oesophageal adenocarcinoma. Fathering children was associated with a reduction in oesophageal squamous cell carcinoma in unadjusted analysis (HR 0.48, 95% CI 0.24, 0.97); however, after adjustment for potential confounders, results attenuated and became statistically non-significant (adjusted HR 0.56, 95% CI 0.27, 1.15). Results for gastric adenocarcinoma were broadly similar to that of gastric cancer with a weak positive association observed for male pattern baldness, although not statistically significant (adjusted HR 1.39, 95% CI 0.97, 1.98; p 5 0.07), Table 3 .
Results by gastric cancer location are listed in Table 4 . Male pattern baldness was associated with a non-significant increase in risk of gastric cardia cancer (adjusted HR 1.59, 95% CI 0.97, 2.61, p 5 0.07). Hazard ratios remained elevated with increasing extent of baldness (e.g., frontal and severe vertex baldness; adjusted HR 1.58, 95% CI 0.86, 2.93). An increase in gastric non-cardia cancer in men who reported male pattern baldness was not apparent (adjusted HR 1.13, 95% CI 0.72, 1.76). Similarly, no other significant associations were identified for other hormonal and reproductive factors and risk of gastric non-cardia cancer. Results were similar after additional adjustment for red and processed meat intakes (data not shown).
Discussion
Our study, which utilised prospectively recorded information from the UK Biobank, found little evidence of associations between sex hormone and reproductive factors and risk of oesophageal or gastric cancer in men however frontal male pattern baldness specifically was associated with a significant increase in gastric cancer risk. As this is the first study to evaluate the association between male pattern baldness and risk of gastric cancer, further epidemiological studies are required to replicate our findings.
Because of the integral role of androgenic action in hair loss, previous studies on male pattern baldness and cancer risk have focused on prostate cancer risk. 27, 28 However, in the Health Professionals Follow-Up Study, Keum et al. 29 recently reported that subtypes of male pattern baldness at age 45 (including frontal only baldness and frontal-plusmild-vertex baldness) were significantly associated with an increased risk of colon cancer, a cancer which also demonstrates a sex disparity in incidence, albeit not as marked as oesophageal or gastric cancer. 23 The authors found similar effects for reproductive factors in women and went on to suggest the possibility of confounding by non-hormonal exposures. 23 Nevertheless, fatherhood and number of children have been shown to independently influence testosterone levels in men. 30 Differences in methodologies may partly explain the discrepancies with our findings; for example, information on number of children fathered was obtained from Swedish registries whereas we used self-report measures. Similar to our study although, Lu et al. found no significant relationship for increasing number of children fathered. 23 In women, although results from individual studies have been inconsistent, pooled analyses have found positive associations for menopause 31 and inverse associations for breastfeeding, 31, 32 longer years of fertility 33 and HRT use, 31, 33, 34 providing some support that endogenous and exogenous oestrogen exposure may lower oesophageal and gastric cancer risk in women.
The weak evidence of an association between frontal baldness and gastric cancer risk is difficult to interpret and requires confirmation. If real, this could reflect that male pattern male pattern baldness, or androgenetic alopecia, is mediated by dihydrotestosterone, the potent metabolite of testosterone. 35 There is growing evidence suggesting that male pattern balding status could serve as a clinical marker for circulating sex hormone concentrations. [36] [37] [38] Moreover, preclinical experimental evidence supports a gastric cancerpromoting effect for testosterone 12 and androgen receptor overexpression in vivo has been shown to promote cell migration, invasion and proliferation in gastric cancer. 20 Taken together, it is possible that androgens might play a role in the development of these cancers, and could provide a logical explanation for the male dominance in their incidence. Better understanding of whether androgen receptors influence the development of oesophageal and gastric cancer is essential considering that intervention before malignancy presents an opportunity for prevention.
Few studies have investigated circulating testosterone levels in relation to risk of oesophageal or gastric cancer. An Irish population-based case-control study identified a higher ratio of androgens to oestrogens in oesophageal adenocarcinoma patients compared to controls, something which was particularly marked for testosterone:oestradiol ratio. 39 In a small case-control study of 33 individuals, pre-operative serum testosterone levels were found to be significantly higher in oesophageal adenocarcinoma patients compared to age-matched controls. 17 However, testosterone levels were measured following oesophageal adenocarcinoma diagnosis and following surgery, testosterone levels in oesophageal adenocarcinoma cases decreased to levels of the controls. 17 Barrett's oesophagus, the precursor of oesophageal adenocarcinoma, has been positively associated with circulating free androgens in men 40, 41 and was particularly marked in men with higher waist-to-hip ratios. 41 These results suggest that the balance of androgens to oestrogens could be important in the progression from Barrett's to oesophageal adenocarcinoma but cautious interpretation is required as sex hormone levels were measured post-diagnosis (in cases) meaning reverse causality cannot be ruled out. 17, [39] [40] [41] Population-based studies with prospective blood collection are therefore required to replicate these findings. No study has investigated the influence of circulating sex hormone levels on gastric cancer risk. Although we adjusted all analyses for both BMI and waist-hip ratio as measures of total and abdominal 1 By pack years (light 5 <20 pack-years; heavy 5 >20 pack-years). 2 Light-moderate (special occasions, 1-3 times per month, <14 units/week), heavy (>14 units/week). 3 Based on International Diabetes Federation criteria (>94 cm in men; >80 cm in women).
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obesity, respectively, further study of the interaction between obesity, androgens and male gender in the genesis of upper gastrointestinal cancers is required. Given that abdominal obesity is particularly associated with both oesophageal adenocarcinoma and gastric cancer risk 42 and obese individuals generally have lower circulating levels of androgens 43, 44 (possibly due to the conversion of testosterone to oestrogens by aromatase, 45 detailed investigation of steroid hormone metabolism in adipose tissue located in close proximity to the oesophagus and stomach is also warranted.
Strengths and weaknesses
We utilised a large, well-characterised, population-based cohort of middle-aged men with prospectively collected information on hormonal and reproductive factors, therefore minimising biases associated with retrospective study designs. 
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Linkage to national cancer registries allowed for robust verification of oesophageal and gastric cancer cases and allowed for analysis by histological subtype and tumour location. The availability of detailed information on a range of lifestyle factors including anthropometric measures and dietary intake (e.g., fruit and vegetable intake) was also of benefit to limit potential confounding. We were unable to account for dietary factors that have previously been implicated with sex hormones, for example isoflavones and phyto-oestrogens, 46, 47 however epidemiological studies have failed to show associations between intake of these compounds and circulating sex hormone concentrations. 48, 49 There was missing data for a small proportion of participants meaning that we cannot rule out the potential for residual confounding. Data on hormonal and reproductive factors was self-reported and was therefore subject to misclassification. This may be particularly relevant for information recalled from decades prior to study recruitment such as relative age at first voice broke and relative age at first facial hair. Studies in women however have indicated that early hormonal factors such as age at menarche are recalled with reasonable accuracy 50 which may extend to men. Moreover, the validity of self-reported male pattern baldness in epidemiological studies has been shown to have sufficient accuracy to ensure reliability and validity of results. 51 The UK Biobank had a relatively low participation response rate of 5% which could suggest that it is not representative of the sampling population and there may be potential for 'healthy volunteer' selection bias. However, considering its large size and population variability in exposures, valid assessment of exposure-disease relationships may be widely generalisable and does not require participants to be representative of the population at large. 24, 52 Approximately 95% of the UK Biobank cohort is of white ethnicity; therefore, our results may not be generalisable to other ethnicities. Despite the large size of our cohort, some sub-group analyses by tumour type were limited by small numbers, in particular oesophageal squamous cell carcinoma. Gastroesophageal reflux is a strong risk factor for oesophageal adenocarcinoma and, although we did not have reliable information on reflux in the UK Biobank, the prevalence of this exposure and the effect on oesophageal adenocarcinoma risk have been shown to be similar in both men and women 53 Indeed, associations between reflux with oesophageal adenocarcinoma in females have been reported to be similar if not stronger compared to males, 54 suggesting that reflux is unlikely to be hormonally mediated. We did not have information on Helicobacter pylori (H. pylori) status of participants but H. pylori has shown a similar prevalence in men and women 55, 56 and previous studies in females indicate that baseline H. pylori serostatus does not modify associations between hormonal and reproductive factors and risk of gastric cancer. 57 , 58 We did not have robust information on prior Barrett's oesophagus, the precursor condition to oesophageal adenocarcinoma; however, only a small proportion of subjects with known Barrett's oesophagus progress to oesophageal adenocarcinoma. 59 Finally, although we had information on a range of Cancer Epidemiology surrogate markers for lifetime sex hormone exposure, which enabled novel investigations of upper gastrointestinal cancer risk, prospective studies with direct assessments of circulating oestrogen and androgen concentrations (as well as their ratios) are needed to provide a more accurate assessment of the role of sex hormones in these malignancies.
Conclusion
In conclusion, in the first prospective study to investigate a range of male hormonal factors and risk of oesophageal and gastric cancer, there was suggestive evidence that male pattern baldness may be associated with an increased gastric cancer risk. Considering the complex patterns of expression of both oestrogen and androgen receptors in oesophageal and gastric cancer, prospective studies of the association between sex steroid hormone levels (as well as their ratios) and risk of upper gastrointestinal cancers in both sexes are required.
